VET Cell Techsp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Vet Cell Tech is a veterinary biotech company from Poland that develops innovative stem cell-based therapies for dogs and cats. They utilize a proprietary stem cell technology platform to create effective treatments for common diseases in companion animals. The company focuses on ensuring high safety profiles and cost-effectiveness in their products.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2023-04-12. Active
56 1090 2590 0000 0001 5345 1825
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
7 public aid cases recorded, with a total value of $2,177,505.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 1, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $55,240 | OIC Poland Fundacja Akademii Wsei | |
| Sep 23, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $52,722 | Marszałek Województwa Małopolskiego | |
| Dec 18, 2024 | Regional investment aid | $461,602 | Marszałek Województwa Małopolskiego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-10-01 | Badania nad zastosowaniem terapii komórkowej w leczeniu dysfunkcji układu moczowego u zwierząt towarzyszących (suki) | $52,722 | Fundusze Europejskie dla Małopolski 2021-2027 | |
| 2024-08-01 | Opracowanie globalnie innowacyjnego leku weterynaryjnego na przewlekłe zapalenie nerek u kotów, opartego o allogeniczne komórki macierzyste oraz wdrożenie produkcji w warunkach standardu farmaceutycznego GMP | $1,601,017 | Fundusze Europejskie dla Małopolski 2021-2027 | |
| 2024-07-01 | Zakup infrastruktury do prowadzenia prac B+R nad hodowlami komórkowymi w warunkach sterylnych w celu opracowania globalnie innowacyjnych weterynaryjnych terapii komórkowych | $468,526 | Fundusze Europejskie dla Małopolski 2021-2027 |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marcin Krzysztof Liwoch (53) | 168 | $2,269.04 | 13.2806% |
Marcin Marek Majka (54) | 550 | $7,428.42 | 43.4783% |
Konrad Grzegorz Szczukiewicz (37) | 163 | $2,201.51 | 12.8854% |
Piotr Antoni Sznelewski (57) | 153 | $2,066.45 | 12.0949% |
Others | 231 | $3,119.94 | 18.2608% |
Beneficial owners
| Person | Rights |
|---|---|
Marcin Krzysztof Liwoch (53)  | Shareholder of a limited liability company, 7500.0 PLN |
Marcin Marek Majka (54) | Shareholder of a limited liability company, 27500.0 PLN |
Konrad Grzegorz Szczukiewicz (37) | Shareholder of a limited liability company, 7500.0 PLN |
Piotr Antoni Sznelewski (57) | Shareholder of a limited liability company, 7500.0 PLN |
Competitors
Selected automatically: mainly by similarity of the business description, plus comparable revenue, industry (PKD code) and location. Only companies with a complete profile (including a logo and financial data) are shown. The list is indicative.
| Name | Revenue | Website | |
|---|---|---|---|
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | |
| COS LabP.S.A. | $1,028,123.83 | coslab.pl | |
| BioceltixS.A. | $616,315.97 | bioceltix.com | |
| OrthogetS.A. | $532,980.53 | orthoget.com | |
| CTI Clinical Trial And Consulting Services Polandsp. z o.o. | $527,145.56 | ctifacts.com | |
| BiottsS.A. | $372,115.60 | biotts.com | |
| MedisensonicS.A. | $362,572.63 | medisensonic.com | |
| Green ZebrasS.A. | $328,658.91 | whygreenzebras.pl | |
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | |
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl |
Change history
| Date | Event |
|---|---|
| 2025-08-05 | Share capital change (61,050.00 PLN → 63,250.00 PLN) |
| 2025-08-05 | PKD change (Removed: 46.75.Z, 68.20.Z, 71.20.B, 72.11.Z, 72.19.Z, 74.90.Z, 77.40.Z; Added: 21.20.Z, 47.73.Z, 47.92.Z, 71.20.C, 72.10.Z, 74.99.Z, 77.40.B) |
| 2023-09-01 | Share capital change (50,000.00 PLN → 61,050.00 PLN) |
| 2023-03-21 | Entered in the register |
FAQ
Last updated: 2026-07-16